Skip to main content
SpringerLink
Log in

The neuropathologic substrate of Parkinson disease dementia

  • Correspondence
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Aho L, Parkkinen L, Pirttila T, Alafuzoff I (2008) Systematic appraisal using immunohistochemistry of brain pathology in aged and demented subjects. Dement Geriatr Cogn Disord 25:423–432

    Article  CAS  PubMed  Google Scholar 

  2. Apaydin H, Ahlskog JE, Parisi JE, Boeve BF, Dickson DW (2002) Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response. Arch Neurol 59:102–112

    Article  PubMed  Google Scholar 

  3. Barrachina M, Dalfo E, Puig B, Vidal N, Freixes M, Castano E, Ferrer I (2005) Amyloid-beta deposition in the cerebral cortex in dementia with Lewy bodies is accompanied by a relative increase in AbetaPP mRNA isoforms containing the Kunitz protease inhibitor. Neurochem Int 46:253–260

    Article  CAS  PubMed  Google Scholar 

  4. Beach TG, Adler CH, Lue L, Sue LI, Bachalakuri J, Henry-Watson J, Sasse J, Boyer S, Shirohi S, Brooks R, Eschbacher J, White CL 3rd, Akiyama H, Caviness J, Shill HA, Connor DJ, Sabbagh MN, Walker DG (2009) Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction. Acta Neuropathol 117:613–634

    Article  PubMed  Google Scholar 

  5. Braak H, Rub U, Jansen Steur EN, Del Tredici K, de Vos RA (2005) Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology 64:1404–1410

    CAS  PubMed  Google Scholar 

  6. Brooks DJ (2009) Imaging amyloid in Parkinson’s disease dementia and dementia with Lewy bodies with positron emission tomography. Mov Disord 24(Suppl 2):S742–S747

    Article  PubMed  Google Scholar 

  7. Colosimo C, Hughes AJ, Kilford L, Lees AJ (2003) Lewy body cortical involvement may not always predict dementia in Parkinson’s disease. J Neurol Neurosurg Psychiatry 74:852–856

    Article  CAS  PubMed  Google Scholar 

  8. Deramecourt V, Bombois S, Maurage CA, Ghestem A, Drobecq H, Vanmechelen E, Lebert F, Pasquier F, Delacourte A (2006) Biochemical staging of synucleinopathy and amyloid deposition in dementia with Lewy bodies. J Neuropathol Exp Neurol 65:278–288

    CAS  PubMed  Google Scholar 

  9. Dickson DW, Braak H, Duda JE, Duyckaerts C, Gasser T, Halliday GM, Hardy J, Leverenz JB, Del Tredici K, Wszolek ZK, Litvan I (2010) Diagnostic criteria for the neuropathological assessment of Parkinson disease: report of the neuropathology and genetics working group of the second international brainstorming conference on Parkinson disease. Lancet Neurol (in press)

  10. Edison P, Rowe CC, Rinne JO, Ng S, Ahmed I, Kemppainen N, Villemagne VL, O’Keefe G, Nagren K, Chaudhury KR, Masters CL, Brooks DJ (2008) Amyloid load in Parkinson’s disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography. J Neurol Neurosurg Psychiatry 79:1331–1338

    Article  CAS  PubMed  Google Scholar 

  11. Gomperts SN, Rentz DM, Moran E, Becker JA, Locascio JJ, Klunk WE, Mathis CA, Elmaleh DR, Shoup T, Fischman AJ, Hyman BT, Growdon JH, Johnson KA (2008) Imaging amyloid deposition in Lewy body diseases. Neurology 71:903–910

    Article  CAS  PubMed  Google Scholar 

  12. Harding AJ, Halliday GM (2001) Cortical Lewy body pathology in the diagnosis of dementia. Acta Neuropathol 102:355–363

    CAS  PubMed  Google Scholar 

  13. Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG (2008) The Sydney multicenter study of Parkinson’s disease: the inevitability of dementia at 20 years. Mov Disord 23:837–844

    Article  PubMed  Google Scholar 

  14. Hurtig HI, Trojanowski JQ, Galvin J, Ewbank D, Schmidt ML, Lee VM, Clark CM, Glosser G, Stern MB, Gollomp SM, Arnold SE (2000) Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson’s disease. Neurology 54:1916–1921

    CAS  PubMed  Google Scholar 

  15. Jellinger KA, Seppi K, Wenning GK, Poewe W (2002) Impact of coexistent Alzheimer pathology on the natural history of Parkinson’s disease. J Neural Transm 109:329–339

    Article  CAS  PubMed  Google Scholar 

  16. Jellinger KA (2007) Morphological substrates of parkinsonism with and without dementia: a retrospective clinico-pathological study. J Neural Transm Suppl 72:91–104

    Article  PubMed  Google Scholar 

  17. Jellinger KA (2008) Re: In dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution. Neurology 70:407–408

    Article  PubMed  Google Scholar 

  18. Jellinger KA (2008) A critical reappraisal of current staging of Lewy-related pathology in human brain. Acta Neuropathol 116:1–16

    Article  CAS  PubMed  Google Scholar 

  19. Jellinger KA, Attems J (2008) Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease. Acta Neuropathol 115:127–136

    Article  Google Scholar 

  20. Jellinger KA (2009) Editorial: The neurological substrate of Parkinson disease dementia. J Mov Disord 23:1–3

    Google Scholar 

  21. Jellinger KA (2009) Significance of brain lesions in Parkinson disease dementia and Lewy body dementia. In: Giannakopoulos P, Hof PR (eds) Dementia in clinical practice. Front Neurol Neuroscience, vol 24. Karger, Basel, pp 114–125

    Google Scholar 

  22. Jellinger KA (2009) A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders. Biochim Biophys Acta 1792:730–740

    CAS  PubMed  Google Scholar 

  23. Jendroska K, Lees AJ, Poewe W, Daniel SE (1996) Amyloid beta-peptide and the dementia of Parkinson’s disease. Mov Disord 11:647–653

    Article  CAS  PubMed  Google Scholar 

  24. Kalaitzakis ME, Pearce RK (2009) The morbid anatomy of dementia in Parkinson’s disease. Acta Neuropathol 118:587–598

    Article  CAS  PubMed  Google Scholar 

  25. Kovari E, Gold G, Herrmann FR, Canuto A, Hof PR, Bouras C, Giannakopoulos P (2003) Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson’s disease. Acta Neuropathol (Berl) 106:83–88

    Google Scholar 

  26. Lashley T, Holton JL, Gray E, Kirkham K, O’Sullivan SS, Hilbig A, Wood NW, Lees AJ, Revesz T (2008) Cortical alpha-synuclein load is associated with amyloid-beta plaque burden in a subset of Parkinson’s disease patients. Acta Neuropathol 115:417–425

    Article  CAS  PubMed  Google Scholar 

  27. Maetzler W, Reimold M, Liepelt I, Solbach C, Leyhe T, Schweitzer K, Eschweiler GW, Mittelbronn M, Gaenslen A, Uebele M, Reischl G, Gasser T, Machulla HJ, Bares R, Berg D (2008) [11C]PIB binding in Parkinson’s disease dementia. Neuroimage 39:1027–1033

    Article  PubMed  Google Scholar 

  28. Mastaglia FL, Johnsen RD, Byrnes ML, Kakulas BA (2003) Prevalence of amyloid-beta deposition in the cerebral cortex in Parkinson’s disease. Mov Disord 18:81–86

    Article  PubMed  Google Scholar 

  29. Mattila PM, Rinne JO, Helenius H, Roytta M (1999) Neuritic degeneration in the hippocampus and amygdala in Parkinson’s disease in relation to Alzheimer pathology. Acta Neuropathol (Berl) 98:157–164

    Article  CAS  Google Scholar 

  30. Mattila PM, Rinne JO, Helenius H, Dickson DW, Roytta M (2000) Alpha-Synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson’s disease. Acta Neuropathol 100:285–290

    Article  CAS  PubMed  Google Scholar 

  31. Oinas M, Polvikoski T, Sulkava R, Myllykangas L, Juva K, Notkola IL, Rastas S, Niinisto L, Kalimo H, Paetau A (2009) Neuropathologic findings of dementia with Lewy bodies (DLB) in a population-based Vantaa 85+ study. J Alzheimers Dis 18:677–689

    PubMed  Google Scholar 

  32. Parkkinen L, Soininen H, Laakso M, Alafuzoff I (2001) Alpha-synuclein pathology is highly dependent on the case selection. Neuropathol Appl Neurobiol 27:314–325

    Article  CAS  PubMed  Google Scholar 

  33. Parkkinen L, Kauppinen T, Pirttila T, Autere JM, Alafuzoff I (2005) Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia. Ann Neurol 57:82–91

    Article  CAS  PubMed  Google Scholar 

  34. Parkkinen L, Pirttila T, Alafuzoff I (2008) Applicability of current staging/categorization of alpha-synuclein pathology and their clinical relevance. Acta Neuropathol 115:399–407

    Article  PubMed  Google Scholar 

  35. Sabbagh MN, Adler CH, Lahti TJ, Connor DJ, Vedders L, Peterson LK, Caviness JN, Shill HA, Sue LI, Ziabreva I, Perry E, Ballard CG, Aarsland D, Walker DG, Beach TG (2009) Parkinson disease with dementia: comparing patients with and without Alzheimer pathology. Alzheimer Dis Assoc Disord 23:295–297

    Article  PubMed  Google Scholar 

  36. Selikhova M, Williams DR, Kempster PA, Holton JL, Revesz T, Lees AJ (2009) A clinico-pathological study of subtypes in Parkinson’s disease. Brain 132:2947–2957

    Article  CAS  PubMed  Google Scholar 

  37. Soto C, Estrada LD (2008) Protein misfolding and neurodegeneration. Arch Neurol 65:184–189

    Article  PubMed  Google Scholar 

  38. Strobel G (2009) Meeting report: the spectrum series: grappling with the overlap between Alzheimer’s and Parkinson’s diseases. J Alzheimers Dis 18:625–640

    PubMed  Google Scholar 

  39. Thomas A, Ballard C, Kenny RA, O’Brien J, Oakley A, Kalaria R (2005) Correlation of entorhinal amyloid with memory in Alzheimer’s and vascular but not Lewy body dementia. Dement Geriatr Cogn Disord 19:57–60

    Article  CAS  PubMed  Google Scholar 

  40. Wu E, Lipton RB, Dickson DW (1992) Amyloid angiopathy in diffuse Lewy body disease. Neurology 42:2131–2135

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Clinical Neurobiology, Kenyongasse 18, 1070, Vienna, Austria

    Kurt A. Jellinger

Authors
  1. Kurt A. Jellinger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kurt A. Jellinger.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jellinger, K.A. The neuropathologic substrate of Parkinson disease dementia. Acta Neuropathol 119, 151–153 (2010). https://doi.org/10.1007/s00401-009-0613-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00401-009-0613-1

Keywords

Search

Navigation